Mary Lou Chatterton, PharmD
Advertisement
Articles by Mary Lou Chatterton, PharmD
Advertisement
Latest Updated Articles
- The Family Impact and Costs of Migraine
May 1st 2004
Advertisement
Advertisement
Trending on AJMC
1
5 August FDA Approvals Marked by Novelty, Pushback
2
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
60% of US Women Face Barriers to Postpartum, Mental Health Care
5